GO analysis of genes with decreased expression (<0.5) in <i>pab2</i>Δ. by Ziyue Liu (381532)

Inhibition of NEAT1 decreased the miR-204-5p expression and increased Six1 expression. by Lei Li (29537)

Data Sheet 1_Emotional prompting amplifies disinformation generation in AI large language models.docx by Rasita Vinay (21006911)

“…Introduction<p>The emergence of artificial intelligence (AI) large language models (LLMs), which can produce text that closely resembles human-written content, presents both opportunities and risks. …”

Feasibility of AI-powered assessment scoring: Can large language models replace human raters? by Michael Jaworski III (22156096)

Additional file 5 of Decreased complement 4 and interleukin-10 as biomarkers in aqueous humour for non-exudative age-related macular degeneration: a case control study by Juliane Schikora (20871169)

Madrasin decreases transcription of protein-coding genes. by Michael Tellier (8284752)

Madrasin decreases transcription of protein-coding genes. by Michael Tellier (8284752)

Validation of genetic markers for risk of OA or knee OA for decrease in minJSW. by Mieke L. M. Bentvelzen (21594442)

Nineteen SNPs with significant association (<i>P < </i>5 × 10⁻⁸) with risk on minJSW decrease in knee OA. by Mieke L. M. Bentvelzen (21594442)

Disruption of putative host factor LGMN decreases SARS-CoV-2 viral entry. by Ravi K. Dinesh (21736629)

Assessment of conditions associated with decrease in systemic vascular resistance one month prior to NAION onset and in matched controls. by Jasmin Gabbay (20323916)

Table 1_Previous treatment decreases efficacy of pralsetinib in RET fusion-positive non-small-cell lung cancer.doc by Lei Wang (6656)

“…The ARROW trial revealed that RET fusion-positive non-small-cell lung cancer (NSCLC) can benefit from pralsetinib with tolerable adverse events (AEs). …”

Superimposed structures of deleterious variants C321R(5a), I151N(5b), K142M(5c), L189P(5d), M179R(5e), and S184L(5f). by Wei Fan (109074)

Non-randomized trial assessments. by Suzanne M. Connolly (21512209)

Annual treatment frequencies in recurrence and non-recurrence groups. by Yasuyuki Sotani (20114144)

“…In the non-recurrence group, the respective preoperative treatment counts were 2.6 ± 1.1, 0.5 ± 0.9, 0.6 ± 0.9, 0.1 ± 0.3, and 3.8 ± 1.3, and no additional treatments were required during the 3 postoperative years. …”

LncRNA <i>C5orf64</i> polymorphisms (rs12518552 and rs2950218) decreases pulmonary tuberculosis susceptibility by Shilin Xu (1884217)

Cell cycle-specific expression of Clb1 and Clb2 protein was also decreased in the <i>puf5</i>Δ mutant. by Megumi Sato (4116994)

Developmental status of non-eclosing <i>Cotesia ruficrus.</i> by Xian Li (201841)

Presentation 1_Tracking priming-induced language recovery in aphasia with pre-trained language models.zip by Yan Cong (1491478)

Data Sheet 1_Tracking priming-induced language recovery in aphasia with pre-trained language models.zip by Yan Cong (1491478)